My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every-time.
Start Systematic Stock Investing ...in less than a minute.
BSE: 523489 | NSE: | Hospital & Healthcare Services | Small Cap
1. Is Chennai Meenakshi Multispeciality Hospital Ltd a good quality company?
Past 10 year's financial track record analysis by Moneyworks4me indicates that Chennai Meenakshi Multispeciality Hospital Ltd is a good quality company.
2. Is Chennai Meenakshi Multispeciality Hospital Ltd undervalued or overvalued?
The key valuation ratios of Chennai Meenakshi Multispeciality Hospital Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
3. Is Chennai Meenakshi Multispeciality Hospital Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Chennai Meenakshi Multispeciality Hospital Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | TTM | |||
| ROCE % ⓘ | 17.2% | 6.2% | 22.7% | -1.6% | 33.9% | 12.4% | 19% | -6.2% | 56.4% | 14.9% | - | ||
| Value Creation Index ⓘ | 0.2 | NA | 0.6 | NA | 1.4 | -0.1 | 0.4 | NA | 3.0 | 0.1 | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 17.9 | 18.9 | 20.5 | 19 | 23.5 | 22.4 | 25.8 | 19.5 | 31.4 | 28.6 | 29 | ||
| YoY Gr. Rt. % | - | 5.5% | 8.8% | -7.5% | 23.5% | -4.7% | 15.2% | -24.4% | 61.1% | -9% | - | ||
| Adj EPS ⓘ | 0.6 | -0.7 | 0.9 | -1.4 | 2 | 0.1 | 0.7 | -1.7 | 5.3 | 1.2 | 0.9 | ||
| YoY Gr. Rt. % | - | -213.3% | NA | -261.4% | NA | -96.5% | 957.1% | -325.7% | NA | -77.1% | - | ||
| BVPS (₹) ⓘ | -6 | -7.3 | -6.5 | -7.7 | -5.6 | -5.5 | -4.8 | -6.4 | -1 | 0.2 | 0.2 | ||
| Adj Net Profit ⓘ | 0.5 | -0.5 | 0.7 | -1.1 | 1.5 | 0.1 | 0.6 | -1.3 | 4 | 0.9 | 1 | ||
| Cash Flow from Ops. ⓘ | 4.3 | 4 | 2 | 2.6 | 2.2 | 2.3 | 3 | 3.3 | 4 | 3 | - | ||
| Debt/CF from Ops. ⓘ | 3 | 3 | 6.2 | 4.7 | 5.6 | 5.3 | 3.8 | 3.5 | 2.7 | 3.6 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | 5.3% | 4% | 3.5% | -9% | ||||||||
| Adj EPS ⓘ | 8.2% | -9.4% | 18.1% | -77.1% | ||||||||
| BVPSⓘ | NA | NA | NA | NA | ||||||||
| Share Price | 19.2% | 19.4% | 51.6% | 31.8% | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | TTM | ||
| Return on Equity % ⓘ | -9.5 | 10.2 | -12.7 | 20.1 | -30.2 | -1.2 | -14.3 | 30 | -143.4 | -278.5 | 460 | |
| Op. Profit Mgn % ⓘ | 14.4 | 11.3 | 14.7 | 6.8 | 16.3 | 9.4 | 9.5 | 3.3 | 18.3 | 10.6 | 9.8 | |
| Net Profit Mgn % ⓘ | 2.5 | -2.7 | 3.2 | -5.6 | 6.4 | 0.2 | 2.1 | -6.4 | 12.7 | 3.2 | 2.4 | |
| Debt to Equity ⓘ | -2.8 | -2.2 | -2.5 | -2.1 | -2.9 | -3 | -3.2 | -2.4 | -13.7 | 87.4 | 59.1 | |
| Working Cap Days ⓘ | 61 | 56 | 51 | 55 | 51 | 65 | 61 | 72 | 42 | 52 | 110 | |
| Cash Conv. Cycle ⓘ | -15 | -13 | -9 | -2 | -4 | -4 | 1 | 2 | -11 | -13 | 0 | |
Return on Equity has increased versus last 3 years average to 460.00%
Net Profit is growing at healthy rate in last 3 years 18.13%
Sales growth has been subdued in last 3 years 3.51%
Debt to equity has increased versus last 3 years average to 87.39
Sales growth is not so good in last 4 quarters at 4.74%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 0.9 | - |
| TTM Sales (₹ Cr.) | 28.6 | - |
| BVPS (₹.) ⓘ | 0.2 | - |
| Reserves (₹ Cr.) ⓘ | -7 | - |
| P/BV ⓘ | 126.57 | - |
| PE ⓘ | 33.09 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 17.00 / 33.00 |
| All Time Low / High (₹) | 1.10 / 41.50 |
| Market Cap (₹ Cr.) | 22.7 |
| Equity (₹ Cr.) | 7.5 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 76.5 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Chennai Meenakshi Multispeciality Hospital Limited (CMMH), formerly known as Devaki Hospital was incorporated on May 13, 1992.
It is a 100-bedded hospital located in the heart of Chennai at Mylapore , it is headed by its CEO, Dr.V.Krishnamurthy, an eminent Rheumatologist. He is ably assisted by a team of dedicated specialists whose USP is commitment, empathy, professional skill, expeditious response and quality care at affordable cost.
Its Services:
The hospital has following specialists :
Its departments:
1) Cardiology Department: There are the following facilities for non-invasive evaluation of cardiac patients
ECG machine
Echocardiography machine (Aloka) SSD 4000
Treadmill machine (Schillers)
Essential evaluation is carried out by cardiologists on a daily basis.
2) Casualty Department
There is a casualty Department which is manned 24 hours with a Duty doctor and Paramedical team. Emergencies and trauma of all kinds are attended to. Specialist’s services are sought for wherever the needs arises. Trauma and accident care receives special attention round the clock.
3) Diagnostic Services:
Laboratory: There is a well equipped modern laboratory functional round-the-clock and manned by an efficient staff.
C.T.SCAN and X-Ray machine: A state-of-art CT scan is available for various diagnostic purposes and manned 24 hours for any emergency services. 24 hours x-ray services are also available.
Ultrasound machine/Echocardiography: The Aloka system, a modern and state-of-art machine is used to perform ultrasound evaluation and echocardiography; the procedures are done by specialists in the field.
TreaMill machine: The latest version of Schillers treadmill machine is available for evaluatin I ardiac patients. All tests are only done by the cardiologist.
4) Intensive Care Unit:
There is a well equipped 12-bedded IMCU I ICCU which is manned 24 hours by efficient, well-trained staff and duty' doctors. There are state-of-art bedside monitors, ventilators, CPAP machines, defibrillators and other supportive equipments ( syringe pumps, diginfusers, nebulizers,' central oxygen and central suctioning) for handling all forms of medical and cardiac emergencies.
5) Nephrology Department6) Physiotherapy Department
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
